Autopsy report · NCT00006054
Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
Cause of deathNo reason given
Life of this trial
- Registered 4 months after it had already started.
- Ran for about 2 years 9 months before it stopped.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Fairview University Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Immunologic Deficiency Syndromes; Chediak-Higashi Syndrome; Common Variable Immunodeficiency; Graft Versus Host Disease; X-Linked Lymphoproliferative Syndrome; Familial Erythrophagocytic Lymphohistiocytosis
- Interventions
- anti-thymocyte globulin; busulfan; cyclophosphamide; cyclosporine; etoposide; methotrexate
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.